RASHIDA LEE: Open Payments
NPI 1740698430 · CERRITOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 9 payments from 5 companies in 2025. Trend: 2023 $122 · 2024 $599 · 2025 $839
Food & beverage: $750Education: $88
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $358 |
| Neurocrine BioSciences, Inc. | 1 | $139 |
| ABBVIE INC. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $81 |
Products named: UZEDY, INGREZZA, VRAYLAR, AUSTEDO XR, REXULTI, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
